Skip to main content
  • Contact Us
  • Vantage logo Sign Up
  • Subscriber Sign In
Evaluate Logo

navigation

  • What We Do
    • Commercial Intelligence
    • Products
      • Evaluate Pharma
      • Evaluate Omnium
      • Evaluate Medtech
      • Evaluate Epi
      • Japan Drug Forecasts
      • Europe Drug Forecasts
    • Pharma Consulting & Analytics
      • Pharma Consulting & Analytics
      • Data Feeds and APIs
    • Evaluate Vantage
      • News
      • Analysis
      • Policy & Pricing
      • Insights
      • Events
      • Medtech
      • Therapy Areas
      • Editorial Team
      • About Evaluate Vantage
    • Evaluate for Biotech
  • How We Can Help You
    • Pharma and Biotech
    • Financial Services
    • Management Consultancies
    • Service Providers
    • Customer Testimonials
  • Thought Leadership
    • Multimedia
    • Blog
  • About Us
    • Press Releases
    • Media Coverage
    • Executive Team
    • Vision & History
  • Contact Us
  • Sign Up for Evaluate Vantage
  • Talent
  • Subscriber Sign In

 

Vantage logo

Vantage

  • Covid-19
    • Covid-19 Coverage
    • Evaluate Vantage COVID-19 Report
  • News
    • Snippets
    • Deals
    • Trial results
    • Patents and litigation
    • Corporate strategy
  • Analysis
    • Interviews
    • Spotlight
    • Vantage points
    • Vantage views
  • Insights
    • M&A
    • IPO
    • NME approvals
    • Quarterly shareprice performance
    • Venture financing
    • Vantage data points
    • Other data
  • Events
    • Company events
    • Conferences
    • Upcoming events
  • Medtech
  • Therapy Areas
  • About
    • Editorial team

Breadcrumb

  1. Home
  2. Vantage
  3. Pharmaceutical Companies
  4. B Braun Melsungen
Thumbnail
October 15, 2020

Post-Brexit device rules risk the UK falling behind

The new regulatory scheme poses problems – but also opportunities, in the shape of possible alignment with the US.

Thumbnail
June 17, 2019

FDA adcom to pronounce on paclitaxel-coated devices

The recent disappointing sales of drug-coated devices for peripheral arterial disease look likely to become the norm.

Article image
Vantage logo
August 28, 2018

ESC 2018 – Small vessels could make a big difference to B Braun

Balloons are as good as stents, but it can be hard to get cardiologists to change their habits.

Article image
Vantage logo
August 17, 2018

ESC 2018 preview – A possible boost for Abbott, and balloons go up against stents

In a quiet year for medical devices a couple of studies are still worth watching.

Article image
Vantage logo
August 02, 2018

Medtechs prioritise efficiency when it comes to hiring

Big cap medtech is hiring, largely thanks to organic growth.

Vantage logo
May 02, 2018

Medtech in 2024: six years of stability, or as wild as the past?

Vantage logo
August 05, 2015

Fewer, but bigger: medtech jobs jump thanks to mergers

Vantage logo
April 13, 2015

Vantage point – medtech corporate VCs move into the valley of death

Vantage logo
July 14, 2014

Event – US approval for TissuGlu could make Cohera a takeover target

Vantage logo
April 30, 2014

2020 will see new forces emerge in $500bn medtech sector

Vantage logo
October 16, 2013

Fresenius hospital takeover in doubt after blocking move by Braun

  • Load More
We use cookies on this website. By using this site, you agree that we may store and access cookies on your device. Find out more.
Vantage logo
Independent, data-driven daily news and analysis on pharma, biotech and medtech.
Sign up

Latest Reports

August 12, 2022

Q2 Roundup Infographic

August 10, 2022

Q2 Roundup eBook

View more...

Editor's Picks

Vantage logo
July 27, 2022

Aids 2022 preview – Gilead shoots for an HIV cure

Vantage logo
July 21, 2022

Private equity gets serious about drug development

Vantage logo
July 18, 2022

Unpacking Royalty Pharma

Vantage logo
July 19, 2022

No plain sailing for Novartis’s PD-1 plan

Vantage logo
July 26, 2022

Move over Aduhelm, it’s tofersen’s turn

Open modal

Evaluate Logo

Evaluate HQ
44-(0)20-7377-0800

Evaluate Americas
+1-617-573-9450

Evaluate APAC
+81-(0)70-4131-0112

Footer menu

  • Terms and conditions
  • Privacy Policies
  • Cookie Policy

© Copyright 2022 Evaluate Ltd.